Swissray International Announces Promotions in The Americas

ELIZABETH, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Swissray International Chairman and Chief Executive Officer Terry Ross announced a series of promotions intended to strengthen and streamline North American operations. Said Ross: “With these promotions we now have in place an outstanding group of leaders in The Americas. They have hit the ground running and proven their value to Swissray.”

Cameron Cox was promoted to Vice President of Sales for the North Eastern Region of the US. Cameron joined Swissray International as a Regional Sales Manager in January 2003 and was promoted to the Northeast Director of Sales in January 2004. Cameron has over 20 years of Sales experience in the medical capital equipment field. He has achieved success throughout his career with various sales positions at General Electric, Toshiba Medical, and at Sopha Medical. He has brought a wealth of Sales experience to Swissray and continues to develop and support new sales strategies to penetrate the growing digital radiography market.

Skip Russell was promoted to Vice President of Sales for the Central Region of the US. Skip joined Swissray as a Regional Sales Manager in August of 2003 and was promoted to Director of Sales, Central Region in January 2004. Skip comes to Swissray with over 25 years of medical sales and management experience in the medical market place. He has demonstrated sales success throughout his career with Johnson and Johnson, Acuson and Siemens. Skip has brought a wealth of sales experience to Swissray and continues to develop and support new sales strategies and initiatives including the establishment of a Digital Radiography Center of Excellence program at a major university for Swissray.

Bob Barnes was promoted to Vice President of US Service reporting directly to the CEO. According to Terry Ross, Chairman and CEO of Swissray International, Inc “Bob Barnes has performed admirably in his role as the Director of North American Customer Service. Bob has managed a huge task for Swissray these past two years. He routinely functions as a corporate officer and makes decisions that are always in the best interest of the total company”. Bob’s 25 year background in Radiology/Service includes 15 years of service with General Electric in various management roles as well as formidable positions in Radiology Departments in hospitals in the New England area. Bob has brought a wealth of management experience to Swissray and continues to develop and support new processes to manage our growing opportunities and responsibilities.

About Swissray

Swissray has received from Frost & Sullivan the “Best Product Value” award for their market leading digital radiography systems. This new technology provides high quality medical radiographic images in seconds at a significantly lower cost than conventional or computed radiography because, among other factors, film, imaging plates, cassettes and chemical processing are not required. By utilizing a multifunctional single detector design, Swissray offers an affordable high quality solution for direct digital radiography. Swissray currently provides a full range of DR systems for orthopedic applications, imaging centers, hospitals and emergency departments. All of Swissray’s DR systems include fully automated, remote controlled system positioning. Swissray offers customers choice between their unique 16 bit Quad CCD or amorphous silicon flat panel detector technologies.

For more information about Swissray’s family of ddR solutions, visit the Swissray website at http://www.swissray.com

Disclaimer: Swissray’s common stock is quoted on the Pink Sheets. The Pink Sheets does not require companies whose securities are quoted upon its systems to meet any listing requirements. With the exception of a few foreign issuers, the companies quoted in the Pink Sheets tend to be closely held, extremely small and/or thinly traded. Most do not meet the minimum listing requirements for trading on a national securities exchange, such as the New York Stock Exchange or the NASDAQ Stock Market. Many of these companies (including Swissray) do not file periodic reports or audited financial statements with the Securities and Exchange Commission, making it very difficult for investors to find reliable, unbiased information about those companies. For all of these reasons, companies quoted in the Pink Sheets can be among the most risky investments. That’s why you should take extra care to thoroughly research any company quoted exclusively in the Pink Sheets. Be aware that some broker-dealers are required by SEC Rule 15c2-11 to have some information about the issuer. Ask your broker-dealer whether it has any Rule 15c2-11 information before you invest. Swissray does not undertake any obligation to update the information contained in this press release beyond the published date.

Safe Harbor: This press release may contain forward-looking statements, and as such, may involve risks and uncertainties. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations, are generally identifiable by the use of words such as “believe,” “expect,” “intend,” “anticipate,” “estimate,” “project,” or similar expressions. Swissray’s actual results, performance, actions and achievements may differ materially from the results, performance, actions and achievements expressed or implied in such forward-looking statements. Under the Private Securities Litigation Reform Act of 1995 Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of Swissray officials during presentations about Swissray, are “forward- looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”).

CONTACT: John Monahan Swissray International, Inc. (908) 353-0971 x 112 jmonahan@swissray.com

Swissray International, Inc.

CONTACT: John Monahan, Swissray International, Inc., +1-908-353-0971 ext112, jmonahan@swissray.com

MORE ON THIS TOPIC